Dokter Roel Parys, fysische geneeskunde
0650.874.057 · rovalta.com · 28/09/2026
Dokter Roel Parys, fysische geneeskunde
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODokter Roel Parys, fysische geneeskunde is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Oosterzele.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0650.874.057
- Incorporation
- 30/03/2016
- Legal form
- Private limited company
- Registered office
- Tramstraat 7
9860 Oosterzele · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 10 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 302,1 k € | +4.8% | 288,2 k € | +17.5% | 245,4 k € | +131% | 106,2 k € | -51.4% | 218,4 k € |
| EBITDA | 301,1 k € | +5.1% | 286,4 k € | +17.1% | 244,6 k € | +134% | 104,8 k € | -51.7% | 217 k € |
| Operating result | 264,2 k € | +4.8% | 252,2 k € | +12.7% | 223,8 k € | +146% | 90,8 k € | -55.4% | 203,5 k € |
| Net result | 199,2 k € | +4.2% | 191,2 k € | +13.0% | 169,1 k € | +149% | 68 k € | -48.6% | 132,3 k € |
| Balance sheet | |||||||||
| Equity | 217,9 k € | +3.5% | 210,5 k € | -59.8% | 523,5 k € | +47.7% | 354,4 k € | +23.7% | 286,4 k € |
| Total assets | 564,8 k € | -14.7% | 662,1 k € | -21.7% | 845,6 k € | +13.2% | 747,3 k € | -9.4% | 824,9 k € |
| Cash | 185,1 k € | -6.5% | 198,1 k € | -36.1% | 310,1 k € | -4.7% | 325,4 k € | +4.2% | 312,4 k € |
| Debts | 346,9 k € | -23.2% | 451,5 k € | +40.2% | 322,1 k € | -18.0% | 392,9 k € | -27.0% | 538,5 k € |
| Other | |||||||||
| Workforce | – | 0,0 ETP | 0,0 ETP | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ROEL PARYS | Directorsince 30/03/2016Managersince 30/03/2016ended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/09/2026 | 26/09/2025 | 24/09/2024 | 29/09/2023 | 30/09/2022 | 26/07/2021 |
| General meeting | 03/06/2026 | 04/06/2025 | 04/09/2024 | 07/06/2023 | 28/09/2022 | 02/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 03/06/2026 | 25/09/2026 | Dutch | |
| Abridged model | 31/12/2024 | 04/06/2025 | 26/09/2025 | Dutch | |
| Abridged model | 31/12/2023 | 04/09/2024 | 24/09/2024 | Dutch | |
| Abridged model | 31/12/2022 | 07/06/2023 | 29/09/2023 | Dutch | |
| Abridged model | 31/12/2021 | 28/09/2022 | 30/09/2022 | Dutch | |
| Abridged model | 31/12/2020 | 02/06/2021 | 26/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 31/08/2020 | 31/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 05/06/2019 | 27/09/2019 | Dutch | |
| Abridged model | 31/12/2017 | 06/06/2018 | 25/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 07/06/2017 | 29/09/2017 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
ROEL PARYS | Directorsince 30/03/2016Managersince 30/03/2016ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Tramstraat 7, 9860 OosterzeleCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00524702 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokter Roel Parys, fysische geneeskundeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00524702 |
Events
- 2025Annual accounts 2025199,2 k €↑
- 2024Annual accounts 2024191,2 k €↑
- 2023Annual accounts 2023169,1 k €↑
- 2022Annual accounts 202268 k €↓
- 2021Annual accounts 2021132,3 k €↑
- 2018Annual accounts 2018112,7 k €↑
- 2017Annual accounts 201743,3 k €↓
- 2016Annual accounts 2016111 k €
- 30/03/2016IncorporationPrivate limited company